Warning: The NCBI web site requires JavaScript to function. more...
The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases.
Gabay C, McInnes IB.
Arthritis Res Ther. 2009;11(3):230. Epub 2009 May 19. Review.
Related citations
New cytokine targets in inflammatory rheumatic diseases.
Connell L, McInnes IB.
Best Pract Res Clin Rheumatol. 2006 Oct;20(5):865-78. Review.
Anti-cytokine antibodies for rheumatic diseases.
Atzeni F, Sarzi-Puttini P.
Curr Opin Investig Drugs. 2009 Nov;10(11):1204-11. Review.
At the horizon of innovative therapy in rheumatology: new biologic agents.
Finckh A, Gabay C.
Curr Opin Rheumatol. 2008 May;20(3):269-75. Review.
Anticytokine therapy for osteoarthritis: evidence to date.
Malemud CJ.
Drugs Aging. 2010 Feb 1;27(2):95-115. doi: 10.2165/11319950-000000000-00000.
Joint inflammation and cytokine inhibition in rheumatoid arthritis.
Christodoulou C, Choy EH.
Clin Exp Med. 2006 Mar;6(1):13-9. Review.
[Biological treatment of rheumatic diseases].
Procházková L, Böhmová J, Soucek M.
Vnitr Lek. 2006 Jun;52(6):632-9. Review. Czech.
Garden of therapeutic delights: new targets in rheumatic diseases.
Waldburger JM, Firestein GS.
Arthritis Res Ther. 2009;11(1):206. Epub 2009 Jan 30. Review.
Biologic therapy for inflammatory bowel disease.
Ardizzone S, Bianchi Porro G.
Drugs. 2005;65(16):2253-86. Review.
Emerging cytokine targets in rheumatoid arthritis.
Asquith DL, McInnes IB.
Curr Opin Rheumatol. 2007 May;19(3):246-51. Review.
Anti-cytokines and cytokines in the treatment of rheumatoid arthritis.
Taylor PC.
Curr Pharm Des. 2003;9(14):1095-106. Review.
Agents against cytokine synthesis or receptors.
Yamagata T, Ichinose M.
Eur J Pharmacol. 2006 Mar 8;533(1-3):289-301. Epub 2006 Feb 2. Review.
Therapeutic potential of targeting IL-1 and IL-18 in inflammation.
Braddock M, Quinn A, Canvin J.
Expert Opin Biol Ther. 2004 Jun;4(6):847-60. Review.
Biological response modifiers in the management of rheumatoid arthritis.
Louie SG, Park B, Yoon H.
Am J Health Syst Pharm. 2003 Feb 15;60(4):346-55. Review. Erratum in: Am J Health Syst Pharm.2003 Jun 1;60(11):1095.
Perspective of cytokine regulation for periodontal treatment: fibroblast biology.
Takashiba S, Naruishi K, Murayama Y.
J Periodontol. 2003 Jan;74(1):103-10. Review.
Targeted therapy in rheumatoid arthritis.
Köller MD.
Wien Med Wochenschr. 2006 Jan;156(1-2):53-60. Review.
[Present importance of direct immunologically based intervention strategies using anticytokines in rheumatoid arthritis].
Boehme MW, Gao IK.
Z Rheumatol. 1999 Oct;58(5):251-66. Review. German.
Biological agents in rheumatoid arthritis.
Shankar S, Handa R.
J Postgrad Med. 2004 Oct-Dec;50(4):293-9. Review.
Interleukin-6 and rheumatic diseases.
Lipsky PE.
Arthritis Res Ther. 2006;8 Suppl 2:S4. Epub 2006 Jul 28. Review.
Novel therapies for rheumatoid arthritis.
Tremoulet AH, Albani S.
Expert Opin Investig Drugs. 2006 Nov;15(11):1427-41. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on